Article Details

CAN10 Shows Promise in Early Studies, Supporting Planned Clinical Trial

Retrieved on: 2021-03-23 17:25:50

Tags for this article:

Click the tags to see associated articles and topics

CAN10 Shows Promise in Early Studies, Supporting Planned Clinical Trial. View article details on hiswai:

Excerpt

CAN10 is a monoclonal antibody administered directly into the bloodstream and intended to specifically block the activity of the interleukin 1 receptor ...

Article found on: sclerodermanews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo